RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Frederick P. Bellinger to Methamphetamine

This is a "connection" page, showing publications Frederick P. Bellinger has written about Methamphetamine.
Connection Strength

1.299
  1. Torres DJ, Yorgason JT, Andres MA, Bellinger FP. Methamphetamine Exposure During Development Causes Lasting Changes to Mesolimbic Dopamine Signaling in Mice. Cell Mol Neurobiol. 2022 Oct; 42(7):2433-2438.
    View in: PubMed
    Score: 0.673
  2. Barayuga SM, Pang X, Andres MA, Panee J, Bellinger FP. Methamphetamine decreases levels of glutathione peroxidases 1 and 4 in SH-SY5Y neuronal cells: protective effects of selenium. Neurotoxicology. 2013 Jul; 37:240-6.
    View in: PubMed
    Score: 0.385
  3. Hedges DM, Obray JD, Yorgason JT, Jang EY, Weerasekara VK, Uys JD, Bellinger FP, Steffensen SC. Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway. Neuropsychopharmacology. 2018 05; 43(6):1405-1414.
    View in: PubMed
    Score: 0.132
  4. Andres MA, Cooke IM, Bellinger FP, Berry MJ, Zaporteza MM, Rueli RH, Barayuga SM, Chang L. Methamphetamine acutely inhibits voltage-gated calcium channels but chronically up-regulates L-type channels. J Neurochem. 2015 Jul; 134(1):56-65.
    View in: PubMed
    Score: 0.110
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support